{"pub": "morningstar", "url": "https://morningstar.com/news/dow-jones/201910076996/health-care-down-slightly-as-traders-hedge-on-regulatory-outlook-health-care-roundup", "downloaded_at": "2019-10-07 23:31:15.439898+00:00", "title": "Health Care Down Slightly As Traders Hedge On Regulatory Outlook \u2014 Health Care Roundup", "language": "en", "text": "Health-care companies fell slightly as traders hedged their bets on the likelihood of regulation in the sector.\n\nShares of Vivus rose after one of its obesity-related treatments received approval in a handful of northern European countries.\n\nQuestions remain for the commercialization of Novartis' Zolgensma in a new indication for the treatment of muscular dystrophy, according to analysts at Swiss bank UBS, as reported earlier.\n\nWrite to Rob Curran at rob.curran@dowjones.com\n\n(END) Dow Jones Newswires\n\nOctober 07, 2019 16:46 ET (20:46 GMT)\n\nCopyright (c) 2019 Dow Jones & Company, Inc.", "description": "", "authors": [], "top_image": "https://morningstar.com/assets/img/30241a1.png", "published_at": "2019-10-07"}